These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 575644)

  • 1. Pharmacological & biochemical characterization of antiparkinson drugs in reserpinized mice.
    David J; Kaul CL; Grewal RS
    Indian J Exp Biol; 1979 Aug; 17(8):760-4. PubMed ID: 575644
    [No Abstract]   [Full Text] [Related]  

  • 2. L-DOPA: chemical modifications and biological evaluation.
    Brossi A; Pool W; Sheppard H; Burns JJ; Kaiser A; Bigler R; Bartholini G; Pletscher A
    Adv Neurol; 1974; 5():291-3. PubMed ID: 4474795
    [No Abstract]   [Full Text] [Related]  

  • 3. [Pharmacological study of amantadine, a new antiparkinson drug].
    Mori J; Sato Y; Oashi T; Hitomi M
    Nihon Yakurigaku Zasshi; 1974 Jan; 70(1):119-26. PubMed ID: 4858046
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological study of piroheptine, a new antiparkinson drug, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine. I. Effects on drug-induced tremor and catatonia, and on adrenergic actions.
    Hitomi M; Kumadaki N; Furukawa T; Ito N; Sato Y; Kumada S
    Arzneimittelforschung; 1972 Jun; 22(6):953-61. PubMed ID: 4626187
    [No Abstract]   [Full Text] [Related]  

  • 5. Correlation between brain dopamine levels and 1-dopa activity in anti-Parkinson tests.
    Horst WD; Pool WR; Spiegel HE
    Eur J Pharmacol; 1973 Mar; 21(3):337-42. PubMed ID: 4736076
    [No Abstract]   [Full Text] [Related]  

  • 6. [Epidemic tremor in chickens as a model for the testing of antiparkinson drugs].
    Stern P; Srebocan S; Cvetnić S; Brmalj V
    Acta Biol Med Ger; 1973; 31(3):463-5. PubMed ID: 4775352
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of rigidity and tremor activity in rats by using a new device and its validation by different classes of drugs.
    Nickel B; Kolasiewicz W; Szelenyi I
    Arzneimittelforschung; 1997 Oct; 47(10):1081-6. PubMed ID: 9368698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antireserpine activity of peptides of L-dopa.
    Felix AM; Winter DP; Wang SS; Kulesha ID; Pool WR; Hane DL; Sheppard H
    J Med Chem; 1974 Apr; 17(4):422-6. PubMed ID: 4857423
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiparkinsonian-like effects of Plumbago scandens on tremorine-induced tremors methodology.
    Morais LC; Quintans-Júnior LJ; Franco CI; Almeida JR; Almeida RN
    Pharmacol Biochem Behav; 2004 Dec; 79(4):745-9. PubMed ID: 15582683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible effect of L-dopa on tremor and catatonia induced by alpha-methyl-p-tyrosine.
    Bédard P; Larochelle L; Poirier LJ; Sourkes TL
    Can J Physiol Pharmacol; 1970 Jan; 48(1):82-4. PubMed ID: 4984213
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathophysiology of static tremor in Parkinsonism].
    Stern P; Catović S
    Neuropsihijatrija; 1964; 12(1-4):7-10. PubMed ID: 16305149
    [No Abstract]   [Full Text] [Related]  

  • 12. Levodopa-responsive rubral (Holmes') tremor.
    Vélez M; Cosentino C; Torres L
    Mov Disord; 2002 Jul; 17(4):741-2. PubMed ID: 12210864
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlative neuroanatomical and neuropharmacological study of tremor and catatonia in the monkey.
    Larochelle L; Bédard P; Poirier LJ; Sourkes TL
    Neuropharmacology; 1971 May; 10(3):273-88. PubMed ID: 4397415
    [No Abstract]   [Full Text] [Related]  

  • 14. Metoprolol in the treatment of neuroleptic-induced tremor: case report.
    Chaturvedi SK
    J Clin Psychiatry; 1987 Sep; 48(9):378. PubMed ID: 2887551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of adenosine in drug-induced catatonia in mice.
    Singh A; Kulkarni SK
    Indian J Exp Biol; 2002 Aug; 40(8):882-8. PubMed ID: 12597016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of reboxetine, a representative of new class of antidepressant drugs, selective noradrenaline reuptake inhibitor (NARI), given acutely.
    Rogóz Z; Wróbel A; Krasicka-Domka M; Maj J
    Pol J Pharmacol; 1999; 51(5):399-404. PubMed ID: 10817540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of LY 171555 and CY 208-243 on tremor suppression in the MPTP monkey model of parkinsonism.
    Gomez-Mancilla B; Boucher R; Bédard PJ
    Mov Disord; 1992; 7(1):43-7. PubMed ID: 1348351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T; Schweitzer-Bucher E; Jamet P; Royer M
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract]   [Full Text] [Related]  

  • 19. [Synthesis and testing of potential antiparkinson agents. 2. Biologically active silicium derivatives].
    Friedrich G; Bartsch R; Rühlmann K
    Pharmazie; 1977 Jul; 32(7):394-7. PubMed ID: 909903
    [No Abstract]   [Full Text] [Related]  

  • 20. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.
    Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T
    Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.